Wednesday, June 18, 2025

Twice-a-year shot to prevent HIV approved in U.S.

Packaging for Gilead Science's HIV prevention medication, Yeztugo, (lenacapvir).

The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.



source https://www.cbc.ca/news/health/lenacapvir-fda-1.7564882?cmp=rss

No comments:

Post a Comment